Lakefront Biotherapeutics NV (LKFT) KPIs and segments
Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –
KPIs & segments
Operating metrics and segments that drive Lakefront Biotherapeutics's business
Lakefront Biotherapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|
Research and Development Segment(€M) | 835 | 279 | 118 | 122 | 34.1 | ||
Fee for services segment(€M) | 10.1 | 10.2 | 8.83 | 7.90 | 5.43 | ||
North America(€M) | 796 | 118 | 82.1 | ||||
United States(€M) | 472 | 794 | 117 | 82.1 | 88.6 | 17.1 | |
Europe(€M) | 5.61 | 41.0 | 162 | 45.0 | 40.9 | 22.4 | |
Asia Pacific(€M) | 0.36 | 0.11 | 0.01 | 0.04 | |||
Research and Development Segment(€M) | 407 | -19.7 | -73.6 | 1.14 | -82.0 | ||
Fee for services segment(€M) | 1.13 | 1.75 | 0.09 | -1.79 | -2.69 | ||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2021-03-25.
See a number that looks wrong?